These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 15108252

  • 1. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR, Maluf DG, Stravitz R, Dumur CI, Clark B, Rodgers C, Ferreira-Gonzalez A, Fisher RA.
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [Abstract] [Full Text] [Related]

  • 2. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [Abstract] [Full Text] [Related]

  • 3. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
    Mas VR, Fisher RA, Archer KJ, Yanek KC, Williams B, Dumur CI, Maluf DG.
    Transplantation; 2007 Apr 15; 83(7):973-81. PubMed ID: 17460570
    [Abstract] [Full Text] [Related]

  • 4. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma.
    Tsunedomi R, Iizuka N, Hamamoto Y, Uchimura S, Miyamoto T, Tamesa T, Okada T, Takemoto N, Takashima M, Sakamoto K, Hamada K, Yamada-Okabe H, Oka M.
    Int J Oncol; 2005 Sep 15; 27(3):661-7. PubMed ID: 16077914
    [Abstract] [Full Text] [Related]

  • 5. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 15; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 6. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.
    Hepatology; 1996 Jun 15; 23(6):1304-12. PubMed ID: 8675143
    [Abstract] [Full Text] [Related]

  • 7. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec 15; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 8. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.
    J Viral Hepat; 2005 Nov 15; 12(6):635-41. PubMed ID: 16255765
    [Abstract] [Full Text] [Related]

  • 9. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
    Bureau C, Péron JM, Bouisson M, Danjoux M, Selves J, Bioulac-Sage P, Balabaud C, Torrisani J, Cordelier P, Buscail L, Vinel JP.
    J Gastroenterol Hepatol; 2008 Jan 15; 23(1):78-86. PubMed ID: 18171345
    [Abstract] [Full Text] [Related]

  • 10. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.
    Int J Oncol; 2006 Aug 15; 29(2):315-27. PubMed ID: 16820872
    [Abstract] [Full Text] [Related]

  • 11. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.
    Cancer Res; 2009 Feb 15; 69(4):1358-67. PubMed ID: 19190340
    [Abstract] [Full Text] [Related]

  • 12. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F, Vangieri B, Cecere A, Gattoni A.
    Clin Ter; 2004 May 15; 155(5):187-99. PubMed ID: 15344567
    [Abstract] [Full Text] [Related]

  • 13. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis.
    Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Hashimoto K, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y.
    Oncogene; 2003 May 15; 22(19):3007-14. PubMed ID: 12771952
    [Abstract] [Full Text] [Related]

  • 14. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N, Oka M, Yamada-Okabe H, Hamada K, Nakayama H, Mori N, Tamesa T, Okada T, Takemoto N, Matoba K, Takashima M, Sakamoto K, Tangoku A, Miyamoto T, Uchimura S, Hamamoto Y.
    Int J Oncol; 2004 Mar 15; 24(3):565-74. PubMed ID: 14767541
    [Abstract] [Full Text] [Related]

  • 15. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr 15; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 16. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM.
    J Gastroenterol Hepatol; 2009 Mar 15; 24(3):416-28. PubMed ID: 19054267
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L, Silvestri L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Bottelli R, Mondelli MU, Civardi E, Silini EM.
    Hepatology; 2002 Jul 15; 36(1):195-201. PubMed ID: 12085365
    [Abstract] [Full Text] [Related]

  • 18. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y.
    Cancer Res; 2002 Jul 15; 62(14):3939-44. PubMed ID: 12124323
    [Abstract] [Full Text] [Related]

  • 19. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
    Tsunedomi R, Iizuka N, Yamada-Okabe H, Tamesa T, Okada T, Sakamoto K, Takashima M, Hamaguchi T, Miyamoto T, Uchimura S, Hamamoto Y, Yamada M, Oka M.
    Int J Oncol; 2006 Dec 15; 29(6):1445-51. PubMed ID: 17088983
    [Abstract] [Full Text] [Related]

  • 20. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR, Moharram RA, Mohamed WS, Bahnassy AA, Alam El-Din HM, Abo-Shadi MM, Zayed NA, El-Magzangy H, Abdel-Aziz AO, Esmat G.
    Eur J Gastroenterol Hepatol; 2010 Apr 15; 22(4):450-6. PubMed ID: 19858727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.